Strong Tower Advisory Services Nektar Therapeutics Transaction History

Strong Tower Advisory Services

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 14, 2022	SELL	$3.04 - $5.14 $3,648 - $6,168	-1,200 Reduced 10.13%	10,650 $34,000
Q2 2022 Aug 10, 2022	SELL	$3.17 - $6.17 $21,239 - $41,339	-6,700 Reduced 36.12%	11,850 $45,000
Q1 2022 Apr 14, 2022	SELL	$4.16 - $13.72 $1.81 Million - $5.96 Million	-434,329 Reduced 95.9%	18,550 $100,000
Q4 2021 Jan 18, 2022	BUY	$10.83 - $18.41 $518,832 - $881,967	47,907 Added 11.83%	452,879 $6.12 Million
Q3 2021 Oct 29, 2021	BUY	$13.07 - $18.84 $5.29 Million - $7.63 Million	404,972 New	404,972 $6.91 Million

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $219M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Strong Tower Advisory Services, based on Form 13F filings with the SEC.

Stay updated on Strong Tower Advisory Services with notifications on news.